Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 9/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 3/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.95 |
| ▸ | ACHE | P22303 | 5/20 | 0.84 |
| ▸ | TP53 | P04637 | 1/20 | 0.76 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.76 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.65 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.62 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.61 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.61 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18037687 | 1.00 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL30637395 | 1.00 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL18061374 | 0.96 | ELANE (0.92) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL24075552 | 0.92 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL18061379 | 0.92 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL18037684 | 0.91 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL18037685 | 0.91 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL18061371 | 0.91 | ELANE (0.88) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL18061380 | 0.91 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 | |
| SCHEMBL24075553 | 0.91 | ELANE (1.00) | ELANEALOX5PTGS2ACHETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | disclosed |
| US-10406136-B2 | Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from Paulownia tomentosa as active ingredient | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2019-09-10 | — | — | US | disclosed |
| US-10406136-B2 | Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from Paulownia tomentosa as active ingredient | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2019-09-10 | — | — | US | disclosed |
| US-20160250179-A1 | COMPOSITION FOR SUPPRESSING NEURAMINIDASE ACTIVITY COMPRISING GERANYLATED FLAVONOID DERIVED FROM PAULOWNIA TOMENTOSA AS ACTIVE INGREDIENT | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2016-09-01 | — | — | US | disclosed |
| US-20160250179-A1 | COMPOSITION FOR SUPPRESSING NEURAMINIDASE ACTIVITY COMPRISING GERANYLATED FLAVONOID DERIVED FROM PAULOWNIA TOMENTOSA AS ACTIVE INGREDIENT | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2016-09-01 | — | — | US | disclosed |
| US-20160250179-A1 | COMPOSITION FOR SUPPRESSING NEURAMINIDASE ACTIVITY COMPRISING GERANYLATED FLAVONOID DERIVED FROM PAULOWNIA TOMENTOSA AS ACTIVE INGREDIENT | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2016-09-01 | — | — | US | disclosed |
| CN-105682672-A | Composition for inhibiting neuraminidase activity comprising geranylflavone from paulownia tomentosa as active ingredient | 庆尚大学校产学协力团 | 2016-06-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10406136-B2 | Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from Paulownia tomentosa as active ingredient | NEU2, NEU1, ENGASE | ELANE 62/4885ALOX5 1376/4885PTGS2 829/4885 |
| US-20160250179-A1 | COMPOSITION FOR SUPPRESSING NEURAMINIDASE ACTIVITY COMPRISING GERANYLATED FLAVONOID DERIVED FROM PAULOWNIA TOMENTOSA AS ACTIVE INGREDIENT | NEU2, NEU1, ENGASE | ELANE 62/4885ALOX5 1376/4885PTGS2 829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.